JPMorgan (NYSE: AMJB) prices callable 9.55% notes linked to tech, small-cap and S&P indices
JPMorgan Chase Financial Company LLC is offering $2,237,000 of Callable Contingent Interest Notes due November 10, 2027, fully and unconditionally guaranteed by JPMorgan Chase & Co. The notes pay a monthly contingent coupon of $7.9583 per $1,000 (a 9.55% per annum rate) only if on each Review Date the Nasdaq-100® Technology Sector IndexSM, the Russell 2000® Index and the S&P 500® Index are each at or above 75% of their Initial Values. If any index is below this Interest Barrier on a Review Date, no interest is paid for that month.
JPMorgan may redeem the notes early, in whole, on any Interest Payment Date starting March 10, 2026 (except the first, second and final dates), paying $1,000 plus any due contingent interest. If the notes are not redeemed early and, at maturity, each index is at or above 70% of its Initial Value, investors receive $1,000 per note plus any final contingent interest. If any index finishes below 70%, repayment is reduced in line with the Least Performing Index, and investors can lose more than 30% and up to all of their principal. The estimated value at pricing was $960.60 per $1,000, lower than the $1,000 issue price, reflecting selling commissions, structuring and hedging costs, and the issuer’s internal funding rate.
Positive
- None.
Negative
- None.
FAQ
What are the JPMorgan AMJB Callable Contingent Interest Notes described here?
The notes are structured debt securities issued by JPMorgan Chase Financial Company LLC and fully guaranteed by JPMorgan Chase & Co. They offer and potential return of principal based on the performance of the Nasdaq-100® Technology Sector IndexSM, the Russell 2000® Index and the S&P 500® Index.
What interest can investors earn on these JPMorgan AMJB notes?
For each $1,000 principal amount note, investors may receive a Contingent Interest Payment of $7.9583 per month, which equals a 9.55% per annum Contingent Interest Rate. Interest is paid only if on the relevant Review Date the closing level of each index is at or above 75% of its Initial Value.
How can investors lose principal on these Callable Contingent Interest Notes?
If the notes are not redeemed early and, on the final Review Date, the Final Value of any index is below 70% of its Initial Value, the maturity payment per $1,000 note is calculated as $1,000 plus $1,000 times the Least Performing Index Return. This can result in losing more than 30% of principal and up to the entire amount.
When can JPMorgan redeem these notes early and what do investors receive?
JPMorgan may, at its option, redeem the notes early in whole on any Interest Payment Date other than the first, second and final dates, starting March 10, 2026. On early redemption, investors receive $1,000 per note plus any applicable Contingent Interest Payment for the immediately preceding Review Date, and no further payments are made.
Which market indices determine payments on the JPMorgan AMJB structured notes?
Payments depend on the performance of three indices considered individually: the Nasdaq-100® Technology Sector IndexSM (NDXT), the Russell 2000® Index (RTY) and the S&P 500® Index (SPX). The notes are linked to the Least Performing Index among them, rather than to a combined basket.
Why is the estimated value of these notes lower than the $1,000 issue price?
The estimated value at pricing was $960.60 per $1,000 note. The difference versus the $1,000 price to public reflects selling commissions, projected profits for JPMorgan affiliates for hedging, and the estimated cost of hedging, as well as the issuer’s internal funding rate used in valuing the structured components.
What key risks are highlighted for investors in these JPMorgan Callable Contingent Interest Notes?
The notes involve principal risk if any index falls below its Trigger Value at maturity, no guarantee of any interest if indices stay below the Interest Barriers on Review Dates, credit risk of JPMorgan Financial and JPMorgan Chase & Co., illiquidity risk because the notes will not be listed, and concentration risks tied to technology stocks, small-cap stocks and non-U.S. securities exposures within the referenced indices.